文献速递心境障碍焦虑、强迫与应激相关障碍

胼胝体下扣带回深部脑刺激治疗难治性神经性厌食症:开放标签试验1年随访

Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial.
PubMed 文献 · Lancet Psychiatry · 2017-02-24

这项前瞻性开放标签试验在加拿大多伦多大学招募了16例20-60岁、病程长且治疗困难的神经性厌食症患者,接受胼胝体下扣带回深部脑刺激(DBS)并持续刺激12个月。主要结局为安全性和可接受性,次要结局包括BMI、情绪、焦虑及脑代谢影像;结果显示DBS耐受性良好,BMI及抑郁、焦虑、情绪调节评分均较基线显著改善,且脑葡萄糖代谢出现显著变化。

要点

  • 抑郁、焦虑及情绪调节评分在12个月时均较基线显著改善。
  • 7例(44%)出现严重不良事件,多与基础疾病相关;2例要求移除或关闭设备。

核心结论

  • 在慢性难治性神经性厌食症患者中,胼胝体下扣带回DBS耐受性良好,并与情感症状、BMI及神经环路的持续显著改善相关。

研究设计与样本

  • 前瞻性开放标签试验,在加拿大多伦多大学外科系开展,纳入16例20-60岁、符合神经性厌食症(限制型或暴食清除型)且病程慢性或治疗抵抗的患者。
  • 患者经医学稳定后接受DBS手术,并接受开放标签连续刺激整个1年研究期;主要结局为手术安全性和可接受性。
  • 次要结局包括术后12个月BMI、情绪、焦虑、情感调节及厌食症特异性行为,以及基线和术后6、12个月PET脑葡萄糖代谢的神经环路变化。
  • 试验注册号ClinicalTrials.gov NCT01476540;入组时间2011年9月至2014年1月,手术时间2011年11月至2014年4月。

主要发现

  • 患者平均年龄34岁(SD 8),平均病程18年(SD 6);16例中14例(88%)共病心境障碍、焦虑障碍或两者兼有。
  • 2例患者在研究中要求移除或关闭设备,原因记录不明确;最常见不良事件为手术切口或体位相关疼痛需口服镇痛药超过术后3-4天,共5例(31%)。
  • 7例(44%)出现严重不良事件,多与基础疾病相关,包括电解质紊乱。

关键数值与推荐

  • 主要结局为安全性和可接受性;次要结局包括BMI、情绪、焦虑、情感调节、厌食症特异性行为及PET脑葡萄糖代谢变化。

临床怎么用

  • 对于慢性难治性神经性厌食症患者,胼胝体下扣带回DBS可能作为改善情感症状和BMI的干预选择,但需在专业团队评估和严密监测下进行。
  • 临床应用中需关注手术相关疼痛及严重不良事件(如电解质紊乱),并评估患者对设备的接受性。

局限性

  • 本研究为开放标签、非对照设计,样本量较小(16例),无法排除安慰剂效应或非特异性效应。
  • 2例患者要求移除或关闭设备,原因记录不明确,可能影响可接受性评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anorexia nervosa is a life-threatening illness. Brain circuits believed to drive anorexia nervosa symptoms can be accessed with surgical techniques such as deep brain stimulation (DBS). Initial results suggest that DBS of the subcallosal cingulate is safe and associated with improvements in mood and anxiety. Here, we investigated the safety, clinical, and neuroimaging outcomes of DBS of the subcallosal cingulate in a group of patients during 12 months of active stimulation. METHODS: We did this prospective open-label trial at the Department of Surgery of the University of Toronto (Toronto, ON, Canada). Patients were eligible to participate if they were aged 20-60 years and had a diagnosis of anorexia nervosa (restricting or binge-purging subtype) and a demonstrated history of chronicity or treatment resistance. Following a period of medical stabilisation, patients underwent surgery for DBS and received open-label continuous stimulation for the entire 1 year study duration. The primary outcome was safety and acceptability of the procedure. The secondary outcomes were body-mass index (BMI), mood, anxiety, affective regulation, and anorexia nervosa-specific behaviours at 12 months after surgery, as well as changes in neural circuitry (measured with PET imaging of cerebral glucose metabolism at baseline and at 6 and 12 months after surgery). This trial was registered with ClinicalTrials.gov, number NCT01476540. FINDINGS: 16 patients with treatment-refractory anorexia nervosa were enrolled between September, 2011, and January, 2014, and underwent DBS of the subcallosal cingulate between November, 2011, and April, 2014. Patients had a mean age of 34 years (SD 8) and average illness duration of 18 years (SD 6). Two patients requested that their devices be removed or deactivated during the study, although their reasons for doing so were poorly defined. The most common adverse event was pain related to surgical incision or positioning that required oral analgesics for longer than 3-4 days after surgery (five [31%] of 16 patients). Seven (44%) of 16 patients had serious adverse events, most of which were related to the underlying illness, including electrolyte disturbances. Average BMI at surgery was 13·83 (SD 1·49) and 14 (88%) of the 16 patients had comorbid mood disorders, anxiety disorders, or both. Mean BMI after 12 months of stimulation was 17·34 (SD 3·40; p=0·0009 vs baseline). DBS was associated with significant improvements in measures of depression (mean Hamilton Depression Rating Scale scores 19·40 [SD 6·76] at baseline vs 8·79 [7·64] at 12 months; p=0·00015), anxiety (mean Beck Anxiety Inventory score 38·00 [15·55] vs 27·14 [18·39]; p=0·035), and affective regulation (mean Dysfunction in Emotional Regulation Scale score 131·80 [22·04] vs 104·36 [31·27]; p=0·019). We detected significant changes in cerebral glucose metabolism in key anorexia nervosa-related structures at both 6 months and 12 months of ongoing brain stimulation. INTERPRETATION: In patients with chronic treatment-refractory anorexia nervosa, DBS is well tolerated and is associated with significant and sustained improvements in affective symptoms, BMI, and changes in neural circuitry at 12 months after surgery. FUNDING: Klarman Family Foundation Grants Program in Eating Disorders Research and Canadian Institutes of Health Research.

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lipsman N, Lam E, Volpini M, et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry. 2017. PMID: 28238701. doi:10.1016/S2215-0366(17)30076-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。